Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer? - An urgent call for research

被引：19

作者：

Alifano, M

Benedetti, G

Trisolini, R

机构：

[1] Osped Maggiore Bologna, Chirurg Torac, I-40100 Bologna, Italy

[2] Maggiore Bellaria Hosp, Med Oncol Unit, Bologna, Italy

[3] Maggiore Bellaria Hosp, Unit Thorac Endoscopy, Bologna, Italy

来源：

CHEST | 2004年 / 126卷 / 02期

关键词：

low-molecular-weight heparin; lung cancer; outcome; recurrence; surgery;

D O I：

10.1378/chest.126.2.601

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：601 / 607

页数：7

共 74 条

[1] Epidemiology of lung cancer [J].

Alberg, AJ ;

Samet, JM .

CHEST, 2003, 123 (01) :21S-49S

[2] Surgical treatment of superior sulcus tumors - Results and prognostic factors [J].

Alifano, M ;

D'Aiuto, M ;

Magdeleinat, P ;

Poupardin, E ;

Chafik, A ;

Strano, S ;

Regnard, JF .

CHEST, 2003, 124 (03) :996-1003

[3] Role of low-molecular-weight heparin in the management of acute coronary syndromes [J].

Borja, J .

CURRENT OPINION IN CARDIOLOGY, 2002, 17 (06) :608-612

[4] Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis [J].

Borsig, L ;

Wong, R ;

Feramisco, J ;

Nadeau, DR ;

Varki, NM ;

Varki, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3352-3357

[5]

Burdett S, 1998, LANCET, V352, P257

[6] Follow-up and surveillance of the lung cancer patient following curative-intent therapy [J].

Colice, GL ;

Rubins, J ;

Unger, M .

CHEST, 2003, 123 (01) :272S-283S

[7] Improved cancer mortality with low-molecular-weight heparin treatment: A review of the evidence [J].

Cosgrove, RH ;

Zacharski, LR ;

Racine, E ;

Andersen, JC .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (01) :79-87

[8] TUMOR-CELL SURFACE CARBOHYDRATE AND THE METASTATIC PHENOTYPE [J].

DENNIS, JW ;

LAFERTE, S .

CANCER AND METASTASIS REVIEWS, 1987, 5 (03) :185-204

[9] Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer [J].

Depierre, A ;

Milleron, B ;

Moro-Sibilot, D ;

Chevret, S ;

Quoix, E ;

Lebeau, B ;

Braun, D ;

Breton, JL ;

Lemarié, E ;

Gouva, S ;

Paillot, N ;

Bréchot, JM ;

Janicot, H ;

Lebas, FX ;

Terrioux, P ;

Clavier, J ;

Foucher, P ;

Monchâtre, M ;

Coëtmeur, D ;

Level, MC ;

Leclerc, P ;

Blanchon, F ;

Rodier, JM ;

Thiberville, L ;

Villeneuve, A ;

Westeel, V ;

Chastang, C .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :247-253

[10] Surgical therapy of early non-small cell lung cancer [J].

Deslauriers, J ;

Grégoire, J .

CHEST, 2000, 117 (04) :104S-109S

← 1 2 3 4 5 6 7 8 →